###### Strengths and limitations of this study

-   This study was conducted using a large data set from the inclusive Canadian trauma systems.

-   We explored a large spectrum of a priori conceptual models of the potential relationship between transfusions and clinical variables.

-   Although residual confounding remains a concern, we optimised control for potential bias.

-   We, however, could not perform any evaluation of the impact of haemoglobin thresholds on red blood cell transfusions.

Introduction {#s1}
============

Traumatic brain injury is a major cause of death and long-term disabilities.[@R1] Caring for the most severe cases, usually admitted to the intensive care unit (ICU), requires significant and costly healthcare resources.[@R1] [@R7] [@R8] Care provided to this specific ICU population is the subject of significant research with the aim to establish best practice. Since brain oxygenation is associated with secondary brain injuries,[@R9] [@R10] increasing cerebral oxygen delivery by maintaining higher levels of haemoglobin, through transfusion of red blood cells, has been suggested.[@R9] [@R11] The presumed benefits of red blood cell transfusion, however, might be counterbalanced by potential harms due to inflammatory, thrombotic and immunological effects of transfusion, many of which are not well understood.[@R10] [@R12]

Even though optimal transfusion strategies in this population are uncertain and clinical equipoise exists,[@R4] [@R10] [@R13] blood products are frequently administered to patients who have sustained a traumatic brain injury, with approximately a third receiving red blood cells according to our previous systematic review.[@R2] [@R19] Significant practice variation is also observed.[@R19] [@R20] Furthermore, little is known regarding potential determinants of transfusions, most cohort studies on transfusion in traumatic brain injury having reported no data or only descriptive statistics of potential determinants.[@R19] Also, red blood cell transfusion has been shown to be associated with ICU and hospital lengths of stay in various population,[@R21] even after adjustment for age, trauma or pathology severity and comorbidities. One trial and a subgroup of a large trial conducted specifically in patients with traumatic brain injury[@R25] [@R26] have failed to show significant differences in patient-oriented outcomes between transfusion strategies (transfusion at a high haemoglobin level compared with a low haemoglobin level). Best practices to guide optimal use of red blood cell transfusion in this population remain unclear[@R19] [@R20] and further analyses of the current transfusions practices, their determinants and associated outcomes are needed to best inform the design of a future clinical trial.

The objective of our study was to estimate the frequency of red blood cell transfusion in patients with traumatic brain injury across Canadian health centres. Our secondary aim was to explore potential determinants of and clinical outcomes associated with transfusion. Finally, we wanted to examine effect modification by age, comorbidities and severity of traumatic brain injury on these associations.

Methods {#s2}
=======

Study design, setting and participants {#s2a}
--------------------------------------

We conducted a retrospective cohort study of patients with a moderate to severe traumatic brain injury admitted to Canadian trauma centres. The study was reported in accordance to the Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) statement.[@R27]

Patients were identified in the Canadian *National Trauma Registry*, which is maintained by the *Canadian Institute for Health Information* (see online [supplementary appendix A](#SM1){ref-type="supplementary-material"} for eligibility criteria of the registry). Records from the registry were linked to the *Discharge Abstract Database*, also maintained by the *Canadian Institute for Health Information*. The *Discharge Abstract Database* does not include data from the province of Québec.
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Adult patients (aged ≥18 years old) with a moderate or severe traumatic brain injury defined using *International Classification of Diseases* codes (ICD-10 S06), and Glasgow Coma Scale (GCS) scores (\<13) or intubated on admission, admitted to one of the centres participating to the registry (see online [supplementary appendix A](#SM1){ref-type="supplementary-material"}) between April 2005 and March 2013 were eligible. Since data pertaining to transfusions were collected from the *Discharge Abstract Database*, patients whose records could not be linked to the database were excluded.

Variables {#s2b}
---------

Our primary objective and exposure of interest was the frequency of red blood cell transfusion, which was available in the *Discharge Abstract Database* as a dichotomous variable indicating if a patient had received or not received a transfusion at any time during hospitalisation. Our secondary objectives were to identify the potential determinants of transfusion. Variables related to age, sex, brain injury severity (GCS scores), extracerebral injuries (measured by the Abbreviated Injury Scale (AIS)[@R28]), on-admission comorbidities such as anaemia, bleeding, coagulopathy, sepsis, hypovolemic shock, ischaemic heart disease and cerebrovascular disease (identified with ICD-10 codes according to the literature,[@R29] [@R30] list provided in online [supplementary appendix B](#SM1){ref-type="supplementary-material"}), and surgical procedures (identified using *Canadian Classification of Health Interventions* (CCI) codes, list provided in online [supplementary appendix C](#SM1){ref-type="supplementary-material"}) were extracted. Those variables were also potential confounding factors in the analysis of clinical outcomes. Our tertiary objectives were to evaluate the potential effect of red blood cell transfusion on clinical outcomes, that is, mortality, complications (defined previously in the literature[@R31] [@R32] using ICD-10 codes, list provided in online [supplementary appendix D](#SM1){ref-type="supplementary-material"}), discharge destinations (home or elsewhere), length of hospital stay, length of ICU stay and duration of mechanical ventilation.

When a patient had been admitted to more than one centre for the same injury (eg, transferred from one hospital to another), we aggregated data from both hospital stays and considered it as one trauma hospital stay. For descriptive purposes and when considering cluster effects related to hospitals, we used data from the centre with the highest level of care.

Statistical analysis {#s2c}
--------------------

### Primary objective: frequency of red blood cell transfusion {#s2c1}

We computed the overall incident proportion of patients with traumatic brain injury that received at least one red blood cell transfusion and its 95% CI.

### Secondary objective: potential determinants {#s2c2}

We conducted multivariable analyses to identify baseline factors associated with red blood cell transfusion, including age, sex, comorbidities, traumatic brain injury severity (GCS and head AIS), and serious extracerebral injuries. We constructed robust Poisson models,[@R33] with log link and random intercept at the centre level to take into account the variation in transfusion practices across centres. The final model included all potential determinants identified.

We computed relative weight analyses based on logistic models to evaluate of relative strength of each identified variable associated with transfusion, individually and when grouped according to the nature of the variable (pertaining to patient characteristics or trauma characteristics). The analysis uses variable transformations and creates sets of predictors that are orthogonal to one another in order to compute standardised weights,[@R34] and allowed evaluating the importance of each predictor and their contribution relative to each other in the variation explained by the model.

A SAS macro created by Tonidandel in collaboration with Breton was used to compute the relative weights.

Considering that surgical procedures or interventions associated with bleeding may have occurred after transfusion or may be intermediate factors of multiple causal paths, we did not include them in our main models, but rather constructed alternative models adding an intervention indicator.

### Tertiary objective: patients' clinical outcomes {#s2c3}

We constructed a robust generalised linear mixed model with a Poisson distribution, log link and random intercept at the centre level to evaluate the association between red blood cell transfusion and mortality, presence of at least one trauma complication or hospital-to-home discharge, while adjusting for the previously identified baseline factors (ie, potential determinants of transfusion and confounders).

We evaluated the association between red blood cell transfusion and lengths of ICU and hospital stay with crude mean differences and as the distribution of length of stay was right-skewed, we used a log-transformation and computed adjusted geometric mean ratios in survivors.

Since we considered a short length of stay better than a longer stay and death can shorten hospitalisation, lengths of stay analyses were primarily limited to survivors. In order to avoid the exclusion of patients who died, with length of stay contingent on survival,[@R35] a secondary analysis considered death at discharge in the model. Deaths were equivalent to indefinite stay (the longest ICU stay or hospital stay observed,[@R36] [@R37] ie, 400 and 620 days respectively, with censoring at the end of observation). We constructed proportional hazard models of time to discharge from ICU or hospital, censoring death.[@R37] We computed the inverse of HRs of ICU and hospital discharge to obtain a measure that would be \>1 for unfavourable outcome (lower hazard of being discharged alive; longer stay), and \<1 for favourable outcome (higher hazard of being discharged; shorter stay).

We evaluated association between transfusions and mechanical ventilation duration using multivariable mixed log-linear model, taking into account the cluster effect at centre level. We obtained adjusted geometric mean ratios and their 95% CIs.

### Effect modification/stratified analyses {#s2c4}

We conducted exploratory stratified analysis according to age, comorbidities and traumatic brain injury severity (moderate (GCS 9--12) or severe (GCS 3--8)), these factors being considered potential effect modifiers of the association between red blood cell transfusion and clinical outcomes by the study expert committee. We considered specific groups of baseline comorbidities (ischaemic heart disease, cerebrovascular disease, sepsis and septic shock, hypovolemic shock, bleeding, coagulopathy, anaemia identified using ICD-10 codes) in order to account, at least partially, for clinical heterogeneity of the pathological processes associated with different groups of comorbidities.

### Sensitivity analyses {#s2c5}

In a sensitivity analysis, lengths of stays were evaluated among survivors only and we reconducted the analyses for binary outcomes after excluding patients who died within 24, 48 and 72 hours of trauma since most withdrawal of life-sustaining therapy happened in a short window after trauma[@R6] and death would therefore not be related to transfusion practices, but other factors such as goals of care for which we had no information.

### Treatment of missing data {#s2c6}

Multiple imputation was used for the treatment of missing GCS data. Ten data sets per imputation process were created. We used Markov chain Monte Carlo method, based on a multivariate normal model with 1000 chain iterations. Since GCS is an ordinal variable, we created dummy variables, imputed their values, and transformed them back into an ordinal scale by comparing them to the observed distribution of GCS scores.[@R38] [@R39]

All analyses were conducted using SAS statistical software packages (V.9.3, SAS Institute, Cary, North Carolina, USA). A type I error of 5% was considered.

Results {#s3}
=======

Among the 58 251 patients that could be linked to *Discharge Abstract Database* data, 7062 were adult patients with moderate or severe traumatic brain injury or intubated on arrival (see [figure 1](#BMJOPEN2016014472F1){ref-type="fig"}---flow diagram and [table 1](#BMJOPEN2016014472TB1){ref-type="table"}). Most included patients were admitted in trauma centres situated in Ontario (n=3327; 47.1%) or Alberta (n=1809; 25.6%); others were admitted in British Columbia (n=1313; 18.6%), Nova Scotia (n=415; 5.9%), New Brunswick (n=152; 2.2%) and Saskatchewan (n=46; 0.7%). No data from Prince Edward Island were available. Trauma admissions from Manitoba and Newfoundland could not be linked to the *Discharge Abstract Database* data due to invalid or missing health card numbers. Hospital admissions from the province of Québec do not contribute to the *Discharge Abstract Database* and therefore could not be linked. Most patients were admitted to a level I or II trauma centre (95.8%). Mean age was 48.7 years old (SD 21.7) and most patients were men (73.2%). Median ISS was 26 (IQR 25--36). More than half of included patients were intubated on arrival (55.2%). Most patients (78.0%) did not have any identified comorbidities recorded in the registry. The majority of patients sustained three or more injuries (n=5047, 71.5%).

###### 

Characteristics of participants

  -------------------------------------------------------------------------------------------
  Variables                                             N (%)          Transfused with RBC\
                                                                       n (%)
  ----------------------------------------------------- -------------- ----------------------
  Total                                                 7062 (100.0)   1991 (28.2)

  Age                                                                  

   18--55                                               4336 (61.4)    1346 (67.6)

   56--65                                               823 (11.7)     252 (12.7)

   66--75                                               700 (9.9)      174 (8.7)

   ≥75                                                  1203 (17.0)    219 (11.0)

   Male gender                                          5168 (73.2)    1368 (68.7)

  GCS on admission                                                     

   Moderate (9--12)                                     1509 (21.4)    278 (14.0)

   Severe (3--8)                                        1788 (25.3)    505 (25.4)

   Missing                                              3765 (53.3)    1208 (60.7)

  Intubated on arrival                                  3899 (55.2)    1249 (62.7)

  Extracerebral trauma of serious or greater severity   3339 (47.3)    1417 (71.2)

  Serious injury (AIS≥3) by body region                                

   Head                                                 6682 (94.6)    1839 (92.4)

   Face and neck                                        598 (8.5)      237 (11.9)

   Thorax and abdomen                                   2512 (35.6)    1140 (57.3)

   Spinal                                               655 (9.3)      286 (14.4)

   Upper extremities                                    479 (6.8)      257 (12.9)

   Lower extremities                                    1001 (14.2)    635 (31.9)

   Other                                                43 (0.6)       20 (1.0)

  Invasive interventions\*                              4201 (59.5)    1695 (85.1)

  Number of comorbidities†                                             

   0                                                    5505 (78.0)    1543 (77.5)

   1                                                    1214 (17.2)    334 (16.8)

   ≥2                                                   343 (4.9)      114 (5.7)

  Other specific comorbidities‡                                        

   Ischaemic heart disease                              172 (2.4)      45 (2.3)

   Cerebrovascular disease                              114 (1.6)      39 (2.0)

   Anaemia                                              314 (4.5)      218 (10.9)

   Coagulopathy                                         89 (1.3)       53 (2.7)

   Sepsis                                               79 (1.1)       39 (2.0)

   Hypovolemic shock                                    554 (7.8)      276 (13.9)

   Bleeding/haemorrhage                                 1701 (24.1)    611 (30.7)

  Direct admission                                      3586 (50.8)    1030 (51.7)

  Mechanism of injury                                                  

   MVC                                                  3162 (44.8)    1237 (62.1)

   Fall                                                 2828 (40.1)    543 (27.3)

   Other                                                1072 (15.2)    211 (10.6)
  -------------------------------------------------------------------------------------------

\*See online [supplementary appendix C](#SM1){ref-type="supplementary-material"} for specific codes.

†Based on previous publication,[@R33] see online [supplementary appendix B](#SM1){ref-type="supplementary-material"}.

‡For specific comorbidities, the total of percentages may exceed 100% since they are not mutually exclusive.

AIS, Abbreviated Injury Severity Score; GCS, Glasgow Coma Scale; MVC, motor vehicle collision; RBC, red blood cell.

![Flow diagram. \*Admissions to more than one hospital for the same injury (transfers) were combined to consider only one trauma admission.](bmjopen2016014472f01){#BMJOPEN2016014472F1}

Red blood cell transfusion frequency {#s3a}
------------------------------------

Overall, 1991 patients (28.2%; 95% CI 27.2% to 29.3%) received at least one red blood cell transfusion during their hospital stay. The proportion of patients receiving a red blood cell transfusion varied considerably across centres, 0--43%. Level I and II trauma centre admissions were associated with the highest frequencies (28.9% and 31.0%, respectively), while level III--IV had 3.4% of patients transfused. Red blood cell transfusion also varied between provinces from 16.6% to 34.9%.

Potential determinants {#s3b}
----------------------

Female sex, age, anaemia, coagulopathy, sepsis, bleeding, hypovolemic shock, presence of other comorbidities, GCS \<9, serious trauma to the face, thorax--abdomen, spine, upper and lower limbs were significantly associated with greater frequency of red blood cell transfusion according to our robust Poisson regression model ([table 2](#BMJOPEN2016014472TB2){ref-type="table"}).

###### 

Adjusted\* risk ratios for the association between determinants of red blood cell transfusion

  Effect                                            Risk ratio (95% CI)
  ------------------------------------------------- ---------------------
  Sex                                               1.16 (1.10 to 1.23)
  Age                                               
   18--55                                           1.00
   56--65                                           1.14 (1.04 to 1.24)
   66--75                                           0.96 (0.84 to 1.09)
   ≥75                                              0.81 (0.72 to 0.90)
  Comorbidities                                     
   0                                                1.00
   1                                                1.11 (1.02 to 1.21)
   ≥2                                               1.66 (1.40 to 1.97)
  Other specific comorbidities considered           
   Ischaemic heart disease                          1.19 (0.93 to 1.53)
   Cerebrovascular disease                          1.17 (0.95 to 1.43)
   Anaemia                                          2.10 (1.81 to 2.43)
   Coagulopathy                                     1.37 (1.08 to 1.74)
   Sepsis                                           1.57 (1.23 to 2.01)
   Hypovolemic shock                                1.33 (1.19 to 1.47)
   Bleeding/haemorrhage                             1.12 (1.03 to 1.22)
  Brain trauma severity                             
   Moderate TBI (GCS 9--12)                         0.78 (0.70 to 0.87)
   Serious head injury (AIS≥3)                      0.93 (0.81 to 1.07)
  Serious extracerebral injury by anatomic region   
   Face                                             1.36 (1.22 to 1.51)
   Thorax and abdomen                               1.76 (1.55 to 2.00)
   Spine                                            1.24 (1.08 to 1.43)
   Upper extremities                                1.25 (1.12 to 1.40)
   Lower extremities                                1.88 (1.75 to 2.02)
   Others                                           1.48 (0.96 to 2.29)

\*Adjusted for all covariates in the table.

AIS, Abbreviated Injury Severity Score; GCS, Glasgow Coma Scale; TBI, traumatic brain injury.

Measures of association between determinants and transfusions remained similar when an indicator of interventions with known bleeding risk was added in the robust Poisson model, with the exception of a reduction of the effect size of serious trauma of the lower extremities. In such model, the indicator of interventions was associated with a threefold risk of receiving a red blood cell transfusion (RR 3.00; 95% CI 2.64 to 3.41).

The magnitude of the variation in the mean frequency of red blood cell transfusion among centres was estimated to 10% (95% CI 1% to 67%). The intraclass correlation coefficient, calculated on the covariance parameter for centre clusters (0.96±0.30) indicated that 61% of the total variation in red blood cell transfusion was accounted for by variation in practice across centres after adjustment for patient-level risk factors.

In the relative weights analyses, serious extracerebral injuries were the most important determinant of transfusion accounting for 61% of red blood cell transfusion logit variation explained by the model ([figure 2](#BMJOPEN2016014472F2){ref-type="fig"}). Anaemia on arrival was the most important baseline factor related to the risk of being transfused, with a relative weight of 14% ([figure 2](#BMJOPEN2016014472F2){ref-type="fig"}). Interventions that confer potential bleeding risk accounted for 37% of the variation when considered in the model.

![Potential determinants of red blood cell transfusion (the percentage represents the relative weight of each determinant in terms of the proportion of variation explained by a variable in the model).](bmjopen2016014472f02){#BMJOPEN2016014472F2}

Clinical outcomes {#s3c}
-----------------

### Mortality {#s3c1}

Patients who were transfused with at least one unit of red blood cells had a significantly greater risk of death (adjusted RR 1.23; 95% CI 1.13 to 1.33) compared with patients not transfused. The presence of comorbidities and traumatic brain injury severity were not significant modifiers of the association. Associations between red blood cell transfusion and mortality were stronger in patients ≤55 years than their older counterparts ([table 3](#BMJOPEN2016014472TB3){ref-type="table"}).

###### 

Adjusted\* risk ratios and HRs of outcomes according to the transfusion status

                           N (%)          Mortality, adjusted risk ratios (95%CI)   Complications, adjusted risk ratios (95%CI)   ICU stay, adjusted HRs† (95%CI)   Hospital stay, adjusted HRs† (95%CI)   Discharged home, adjusted risk ratios (95% CI)
  ------------------------ -------------- ----------------------------------------- --------------------------------------------- --------------------------------- -------------------------------------- ------------------------------------------------
  Overall                  7062           1.23 (1.13 to 1.33)                       1.38 (1.32 to 1.44)                           1.63 (1.52 to 1.75)               1.56 (1.45 to 1.67)                    0.53 (0.49 to 0.57)
  Strata                                                                                                                                                                                                   
  Age                                                                                                                                                                                                      
   18--55                  4336 (61.40)   1.54 (1.37 to 1.73)                       1.55 (1.44 to 1.66)                           1.06 (0.85 to 1.33)               1.67 (1.53 to 1.81)                    0.53 (0.48 to 0.58)
   56--65                  823 (11.65)    1.10 (0.94 to 1.28)                       1.26 (1.15 to 1.38)                           1.79 (1.65 to 1.94)               1.24 (1.02 to 1.50)                    0.46 (0.30 to 0.71)
   66--75                  700 (9.91)     1.00 (0.84 to 1.19)                       1.18 (1.05 to 1.32)                           1.38 (1.14 to 1.68)               1.45 (1.15 to 1.83)                    0.55 (0.30 to 1.02)
   ≥75                     1203 (17.03)   0.94 (0.78 to 1.13)                       1.13 (1.01 to 1.26)                           1.31 (1.04 to 1.66)               1.26 (1.01 to 1.58)                    0.60 (0.35 to 1.03)
  GCS                                                                                                                                                                                                      
   Moderate                1788 (25.32)   1.21 (0.98 to 1.49)                       1.55 (1.37 to 1.75)                           1.80 (1.60 to 2.02)               1.61 (1.43 to 1.80)                    0.53 (0.44 to 0.63)
   Severe                  1509 (21.37)   1.23 (1.12 to 1.36)                       1.33 (1.27 to 1.39)                           1.53 (1.40 to 1.67)               1.53 (1.40 to 1.67)                    0.52 (0.47 to 0.59)
  Comorbidities                                                                                                                                                                                            
   0                       5505 (77.95)   1.27 (1.16 to 1.39)                       1.42 (1.36 to 1.49)                           1.67 (1.55 to 1.81)               1.60 (1.48 to 1.74)                    0.51 (0.47 to 0.56)
   1                       1214 (17.19)   1.18 (0.98 to 1.42)                       1.33 (1.19 to 1.48)                           1.51 (1.28 to 1.79)               1.41 (1.20 to 1.66)                    0.51 (0.37 to 0.69)
   ≥2                      343 (4.86)     0.97 (0.74 to 1.26)                       1.07 (0.92 to 1.24)                           1.29 (0.95 to 1.74)               1.35 (0.99 to 1.82)                    0.87 (0.50 to 1.51)
  Specific comorbidities                                                                                                                                                                                   
   Anemic                  314 (4.45)     1.00 (0.72 to 1.40)                       1.00 (0.88 to 1.13)                           1.17 (0.87 to 1.57)               0.95 (0.71 to 1.28)                    0.65 (0.48 to 0.88)
   Non-anemic              6748 (95.55)   1.23 (1.14 to 1.33)                       1.38 (1.33 to 1.44)                           1.62 (1.51 to 1.75)               1.55 (1.43 to 1.67)                    0.52 (0.48 to 0.57)
   Septic                  79 (1.12)      0.36 (0.09 to 1.46)                       1.11 (0.87 to 1.42)                           0.90 (0.54 to 1.50)               2.11 (1.27 to 3.51)                    1.52 (0.72 to 3.19)
   Non-septic              6983 (98.88)   1.23 (1.14 to 1.34)                       1.37 (1.31 to 1.42)                           1.61 (1.49 to 1.73)               1.50 (1.39 to 1.61)                    0.52 (0.48 to 0.57)
   Bleeding                1701 (24.09)   1.15 (0.93 to 1.42)                       1.18 (1.08 to 1.30)                           1.36 (1.20 to 1.55)               1.47 (1.29 to 1.67)                    0.67 (0.55 to 0.82)
   Non-bleeding            5361 (75.91)   1.25 (1.15 to 1.36)                       1.44 (1.39 to 1.50)                           1.68 (1.55 to 1.83)               1.52 (1.40 to 1.65)                    0.50 (0.46 to 0.54)

\*Adjusted for sex, age, comorbidities, GCS, head AIS, square of max extracerebral AIS.

†With death considered as censored at the longest length of stay; value \>1 indicates that patients were at lower risk of being discharge alive (longer stays) and \<1 at higher risk (shorter stays).

AIS, Abbreviated Injury Severity Score; GCS, Glasgow Coma Scale.

### Complications {#s3c2}

A high proportion of patients developed complications (1361 (68%) transfused; 2386 (47%) non-transfused; adjusted RR 1.38 95% CI 1.32 to 1.44). The strength of the association was greater in younger patients as well as those with moderate traumatic brain injury severity or having no comorbidity ([table 3](#BMJOPEN2016014472TB3){ref-type="table"}).

Transfusions in non-anaemic or non-bleeding patients on admission were associated with higher risks of complications. The association was not significant in patients with anaemia, and was weaker in patients who were bleeding on admission.

### Discharge destination {#s3c3}

Patients who were transfused were less often discharged home (RR 0.53; 95% CI 0.49 to 0.57). This association was significant in patients who did not have sepsis on arrival, but was not in patients with sepsis. Patients who were bleeding on arrival showed a weaker effect of transfusion on the risk of being discharged home ([table 3](#BMJOPEN2016014472TB3){ref-type="table"}).

### Length of stay {#s3c4}

In survivors, ICU length of stay was longer (crude mean difference: 18.63 days (95% CI 16.64 to 20.62)) in patients who were transfused red blood cells than those who were not. After applying a correction to the length of stay for patients who died, we obtained ICU stay HRs of 1.63 (95% CI 1.52 to 1.75) between patients who were transfused and those who were not, meaning that patients who were transfused had longer lengths of stay in ICU ([table 3](#BMJOPEN2016014472TB3){ref-type="table"}). The HR for hospital length of stay was 1.56 (95% CI 1.45 to 1.67), indicating a significantly longer length of stay in patients who were transfused compared with those who were not.

ICU lengths of stay were longer following transfusion in strata of non-anaemic, non-septic or non-bleeding patients. No significant differences in length of stay between transfused and non-transfused were observed in patients with anaemia or sepsis. A weaker association between transfusion and ICU length of stay was seen in patients who were bleeding on admission. Hospital lengths of stay were longer following transfusion in non-anaemic patients, but not in anaemic patients ([table 3](#BMJOPEN2016014472TB3){ref-type="table"}).

Patients who were transfused were ventilated for a crude mean of 4.87 more days (95% CI 4.28 to 5.46) than those who were not. The difference remained significant in adjusted models, with adjusted geometric mean ratios of 1.87 (95% CI 1.75 to 1.99).

### Sensitivity analyses {#s3c5}

All unfavourable outcomes were significantly more frequent in patients who were transfused than those who were not. The same observations were made even when adding an indicator of interventions with bleeding risk for adjustment. Excluding patients who died within 24, 48 or 72 hours, in other words limiting the analysis to those who survived at 24, 48 or 72 hours following admission, yielded stronger associations between transfusions and outcomes. Results were similar in analyses of complete observations and multiple imputations.

Discussion {#s4}
==========

Across trauma hospitals in Canada, close to one-third of patients with a moderate or severe traumatic brain injury received a red blood cell transfusion during their hospital stay. Large variation in the frequency of transfusion was present across centres mainly explained by variation in practice across centres. Red blood cell transfusion was more common among patients with extracerebral trauma. After adjusting for confounding factors, patients who received at least one red blood cell transfusion experienced worse clinical outcomes, such as higher mortality, longer length of stay, more complications and discharge elsewhere than home.

The frequency of red blood cell transfusion in our cohort (28%; 95% CI 27% to 29%) was lower than the estimation from our recent systematic review (36%; 95% CI 28% to 44%).[@R20] In both studies, frequencies varied greatly between healthcare settings. Since centre variation remained high when evaluating determinants of red blood cell transfusion, regional practice variations may account for a large part of variations observed in absence of clear consensus. Variability in practices across centres has been previously observed in a large cohort of patients with traumatic brain injury looking at withdrawal of life-sustaining therapy,[@R6] another domain in which data is scarce.

As we observed previously in our systematic review,[@R19] patients with anaemia on admission were at a higher risk of receiving red blood cell transfusion. This is likely due to the fact that haemoglobin usually drops over an ICU stay and red blood cell transfusions are administered with the intention of increasing haemoglobin level and thus oxygen delivery.[@R24] [@R40] Active bleeding on arrival and hypovolemic shock, which can also result from major rapid blood loss, were associated with red blood cell transfusion. Although such conditions are often treated with volume replacement using crystalloids,[@R44] [@R45] early red blood cell transfusion is frequently used as it is included in developed protocols of care for massive transfusion following evidence of benefit from early transfusion of blood products in these situations.[@R44] Considering the high frequency of major bleeding from serious thoraco-abdominal wounds and lower limb fractures,[@R46] [@R47] it is unsurprising that those type of injuries were also associated with higher incidence proportions of red blood cell transfusion. Sepsis was also associated with transfusions in our cohort. It is another factor associated with loss of erythrocytes and also with the limited ability to extract oxygen from blood. In this context, higher haemoglobin levels have been advocated in this population.[@R48] However, no strong evidence supports this approach.[@R49] [@R50] Transfusions were also more frequent in patients with coagulopathy. Even if red blood cell preparations do not include coagulation factors and cannot treat coagulopathy, patients presenting with the latter condition tend to experience prolonged bleeding. Early red blood cell transfusion following trauma might beneficially reduce the risk of coagulopathy.[@R51] Furthermore, trauma-induced coagulopathy increases the risk of major bleeding and use of 1:1:1 platelet:fresh frozen plasma:red blood cell has been advocated by some experts in the prevention or treatment of trauma-induced coagulopathy. However, few evidences support the use of such strategy.[@R52] [@R53] When added to the model, surgical interventions were associated with transfusions. Trauma surgeries can lead to important blood loss, or be initiated in order to control haemorrhage.

We observed worse outcomes in patients who received at least one red blood cell transfusion, which is similar to the results of previous studies.[@R54] When we stratified analyses by anaemic status, the effect of transfusion on complications, and ICU and hospital length of stay were different. Specifically, transfused patients in the non-anaemic strata had significantly higher risk of worse outcome and no such relationship was observed in patients who were anaemic on admission. This is similar to the observations of previous studies,[@R54] [@R57] and illustrates again the importance of considering haemoglobin levels when evaluating the association between red blood cell and patient-oriented outcomes in the context of traumatic brain injury. A recent trial[@R26] failed to observe significant differences over mortality and neurological outcome but was underpowered and not designed to evaluate equivalency of such outcomes. Further analyses of the progressive decline in haemoglobin during ICU stay, pretransfusion haemoglobin level and its impact on optimal transfusion strategies are needed.

Similarly, sepsis was also a modifying factor of the effect of red blood cell transfusion on clinical outcomes. According to our observations, red blood cell transfusion showed neither significant benefit nor disadvantage over clinical outcomes when patients were in sepsis (except for hospital length of stay), but tended to be associated with worse outcomes in patients who did not have sepsis diagnosed on arrival. According to previous studies comparing liberal to restrictive transfusion strategies in populations of septic patients, similar outcomes were observed for both strategies[@R49] leading clinical guidelines to support restrictive use of red blood cell in the treatment of severe sepsis and septic shock.[@R58] As mentioned earlier, patients with sepsis often show decreasing levels of haemoglobin and a reduced ability to extract oxygen from blood. The apparent equivalency between groups of patients who did or did not receive red blood cell in this stratum could be related to important haemoglobin depletion, requiring further investigation of haemoglobin levels.

Strengths and limitations {#s4a}
-------------------------

Level I and II trauma centres across the country are well represented in the registry, and patients with moderate or severe traumatic brain injury are rarely treated outside highly specialised centres.[@R59] Therefore, undercoverage from patients being treated in trauma centres that are not included in the registry or in non-trauma centres should not have had a major effect on our frequency estimate. However, we could not link 21.9% of the National Trauma Registry to the Discharge Abstract Database. Considering that the province of Québec does not contribute to the Discharge Abstract Database of the National Trauma Registry, and that its population represents 23% of Canada\'s population, we can estimate that our study population represents trauma patients in Canada, with the exception of those from the province of Québec. Considering that training of physicians and certifications of trauma centres are managed at a national Canadian level, healthcare delivery is thus likely to be consistent across provinces. More so, referral and triage being independent in each Canadian province, the distribution of trauma severity would thus not be affected by the absence of data from one province. Our study was inclusive and we had a large sample size, and therefore high power. Our statistical plan was strong, with advanced biostatistics methods and conceptual rigour. We used multilevel models, with random effects. This method allowed to account for potential differences in local practices (between centres) in our evaluation of red blood cell transfusions and its potential determinants, as well as associated outcomes. We explored a large spectrum of a priori conceptual models of the potential relationship between transfusions and clinical variables, which we explored with multiple sensitivity and subgroup analyses. Although residual confounding remains a concern, we optimised control for potential bias through multivariate analyses.

Secondary data use has the risk of measurement bias/misclassification and incompleteness of data. However, data quality is monitored by The *Canadian Institute for Health Information*[@R62] assuring a high reliability of data collection and encoding[@R63] and limiting the potential for such errors. It is possible that incomplete assessment of comorbidities, extracerebral injuries and interventions contributed to the underestimation of their frequencies and effect sizes. For example, comorbidity capture depends on what was noted in the hospital chart and may not represent an exhaustive account of all comorbidities present in a given patient at the time of admission. Even with the inclusion of comorbidities as potential confounders in our models of patient-oriented outcomes, residual confounding is possibly present. Similarly, complications are reported differently across trauma centres, screening and coding practices may vary greatly, causing incomplete outcome measurement. Any under-reporting should not be systematically linked to transfusion practices, but may bias our estimates. Furthermore, we had limited information on traumatic brain injury severity, as GCS scores were often missing and the registry do not contain data on clinical findings such as pupillary reflex, which is another indicator of severity and prognostic variable in traumatic brain injury. Although we endeavoured to overcome this limitation with multiple imputation and included information on severity of head trauma (head AIS) in our models, adjustment might still be imperfect.

We did not have data on the quantity of red blood cell units transfused or number of transfusion events. As such, a dose--response relationship could not be evaluated. We also did not have information on haemoglobin levels during hospitalisation, which would have been a more precise measure of the status of the patient than simply the presence of anaemia on admission. We could not evaluate the effect of transfusion strategies (transfusion at different haemoglobin levels).

Owing to the use of secondary data, we could not properly identify and control timing and reasons for identified surgical interventions, so both causal mechanisms are plausible (ie, interventions could increase the risk of transfusions and transfusions might increase the risk of interventions as well). For this reason, we kept adjustment to baseline variables. However, when we added the indicator of interventions, our results remained similar. Furthermore, the registry does not contain information on timing of complications either and thus, we cannot exclude that complications might have contributed to decision to transfuse rather than resulted from it. We were also limited on variables to control for by data available in the registry (eg, data on decisions over the goals of care are not reported), resulting in potential residual confounding. Overall, due to our limited ability to control for factors related to the need or decision to transfuse and clinical outcomes (such as severity of trauma, comorbidities, complications directly related with the trauma, decisions on intensity of care, other interventions), we cannot exclude confounding by indication.

Conclusion {#s5}
==========

In our multicentre cohort study, we observed that red blood cell transfusions were frequent in patients with traumatic brain injury and varied considerably between centres. Trauma severity and invasive interventions are important determinants of transfusion decisions. More so, red blood cell transfusion was associated with increased mortality, prolonged ICU and hospital length of stay and adverse events. However, these associations are potentially confounded considering that transfusions are correlated to worse clinical baseline prognosis, which we could not fully account for in the analyses. Prospective trials are required to better understand the impact of different transfusion strategies on clinical outcomes in which to inform future trials of optimal transfusion strategy for traumatic brain injury.
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